Chronic Spontaneous Urticaria Current and Emerging Biologic Agents

被引：0
|
作者：
Bernstein, Joshua S. [1 ]
Bernstein, Jonathan A. [1 ]
Lang, David M. [2 ]
机构：
[1] Univ Cincinnati, Div Rheumatol Allergy & Immunol, 234 Goodman St, Cincinnati, OH 45219 USA
[2] Cleveland Clin, Dept Allergy & Clin Immunol, 9500 Euclid Ave,A90, Cleveland, OH 44195 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2024年 / 44卷 / 04期
关键词：
Chronic spontaneous urticaria; Mast cell; Biologics; Omalizumab; Siglec-6; BTK inhibitor; MRGPRX2; C-kit; Dupilumab; CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA; MAST-CELLS; OMALIZUMAB; SKIN; CYTOKINES; LIGELIZUMAB; ACTIVATION; EXPRESSION; EOSINOPHIL; ANTIBODY;
D O I：
10.1016/j.iac.2024.07.001
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：595 / 613
页数：19
相关论文
共 50 条
  • [31] Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria
    de Montjoye, L.
    Darrigade, A-S
    Gimenez-Arnau, A.
    Herman, A.
    Dumoutier, L.
    Baeck, M.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 53 (02) : 55 - 66
  • [32] Biologic Agents in the Treatment of Urticaria
    Allen P. Kaplan
    Current Allergy and Asthma Reports, 2012, 12 : 288 - 291
  • [33] Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances
    Kaplan, Allen
    Lebwohl, Mark
    Gimenez-Arnau, Ana M.
    Hide, Michihiro
    Armstrong, April W.
    Maurer, Marcus
    ALLERGY, 2023, 78 (02) : 389 - 401
  • [34] Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis
    Licari, Amelia
    Castagnoli, Riccardo
    De Filippo, Maria
    Foiadelli, Thomas
    Tosca, Maria Angela
    Marseglia, Gian Luigi
    Ciprandi, Giorgio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 609 - 619
  • [35] Management of Pediatric Urticaria with Review of the Literature on Chronic Spontaneous Urticaria in Children
    Ben-Shoshan, Moshe
    Grattan, Clive E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (04) : 1152 - 1161
  • [36] Potential clinical and serological predictors of chronic spontaneous urticaria relapse in patients under omalizumab treatment
    Grieco, Teresa
    Dies, Laura
    Sernicola, Alvise
    Chello, Camilla
    Gagliostro, Nazareno
    Carnicelli, Giorgia
    Paolino, Giovanni
    IMMUNOTHERAPY, 2020, 12 (16) : 1173 - 1181
  • [37] Novel biologics for treatment of chronic spontaneous urticaria
    Casale, Thomas B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (06) : 1256 - 1259
  • [38] Ligelizumab Is Superior to Omalizumab for Chronic Spontaneous Urticaria
    Muntyanu, Anastasiya
    Ouchene, Lydia
    Ben-Shoshan, Moshe
    Netchiporouk, Elena
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2020, 24 (02) : 201 - 202
  • [39] Evidence for bradykinin release in chronic spontaneous urticaria
    Hofman, Zonne L. M.
    van den Elzen, Mignon T.
    Kuijpers, Jeffrey
    de Maat, Steven
    Hack, C. Erik
    Knulst, Andre C.
    Rockmann, Heike
    Maas, Coen
    CLINICAL AND EXPERIMENTAL ALLERGY, 2020, 50 (03) : 343 - 351
  • [40] Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
    Thomas B. Casale
    Ana Maria Gimenez-Arnau
    Jonathan A. Bernstein
    Michael Holden
    Torsten Zuberbier
    Marcus Maurer
    Dermatology and Therapy, 2023, 13 : 2573 - 2588
12345